MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image CELLULAR BIOMEDICINE GROUP
CELLULAR BIOMEDICINE GROUP

CELLULAR BIOMEDICINE GROUP

Summary

Cellular Biomedicine Group operates as a biopharmaceutical company. The Company develops cell therapies for the treatment of cancer.

Deals Overview

Total Deals2
Valued Deals2
Total Value£ 296 M
Avg. Deal Size£ 148 M

Market Context

Sort

27 Sep 2018|China|Biotechnology
Cellular Biomedicine Group
Novartis

Target: CELLULAR BIOMEDICINE GROUP

Bidder: NOVARTIS AG

3 Service Providers

1 Target | 2 Bidder

8 Dealmakers

2 Target | 6 Bidder

£ 2 M

Value

11 Nov 2019|China|Biotechnology
Cellular Biomedicine Group
Tony Bizuo Liu

Target: CELLULAR BIOMEDICINE GROUP

Bidder: TONY BIZUO LIU

10 Service Providers

5 Target | 5 Bidder

66 Dealmakers

42 Target | 24 Bidder

£ 293 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite